LEVIN CAPITAL STRATEGIES, L.P.

Position in BSX — Boston Scientific Corp

CIK 1354821 NEW YORK, NY

Back to BSX Full portfolio

Position in BSX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$6,471,781

-$3,501,704 QoQ

Shares Held

151,635

-4.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#379

of 1,477 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 51% None 49%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Jun 30, 2026

CallValue

$106,700

CallShares

2,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

LEVIN CAPITAL STRATEGIES, L.P. holds $7,493,698 across 4 Medical Devices names. BSX ranks #1 (86.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp This page	151,635	$6,471,781
2	BFLY	Butterfly Network, Inc.	75,000	$631,500
3	ENOV	Enovis CORP	12,000	$248,400
4	CERS	Cerus Corp	48,636	$142,017

All Filings in BSX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,471,781	151,635	-4.6%	Shares	Other	2026-07-31
2026-06-30	$106,700	2,500	+150.0%	Call	Other	2026-07-31
2026-03-31	$62,750	1,000	—	Call	Other	2026-05-13
2026-03-31	$9,973,485	158,940	—	Shares	Other	2026-05-13
No filing history on record for this holder in this stock.